# The Effects of Allicor on Patients After Revascularization Treatment During a Year

> **NCT05813171** · PHASE4 · UNKNOWN · sponsor: **Institute for Atherosclerosis Research, Russia** · enrollment: 300 (estimated)

## Conditions studied

- Atherosclerosis
- Peripheral Arterial Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Allicor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05813171
- **Lead sponsor:** Institute for Atherosclerosis Research, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-20
- **Primary completion:** 2024-04-20
- **Final completion:** 2024-05-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05813171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05813171, "The Effects of Allicor on Patients After Revascularization Treatment During a Year". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05813171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*